Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Oxytocin (OT) subserves various physiological, behavioral, and cognitive processes. This paired with the ability to administer OT with minimal and inconsistent side effects has spurred research to explore its therapeutic potential. Findings from single-dose studies indicate that OT administration may be beneficial, at least under certain circumstances. The state of the field, however, is less clear regarding effects from chronic OT administration, which more closely resembles long-term treatment. To address this gap, this review synthesizes existing findings on the use of chronic OT administration in animal and human work. In addition to detailing the effects of chronic OT administration across different functional domains, this review highlights factors that have contributed to mixed findings. Based on this review, a basic framework of interrelated regulatory functions sensitive to chronic OT administration is offered. The paper also identifies future research directions across different contexts, populations, and outcomes, specifically calling for more systematic and standardized research on chronic OT administration in humans to supplement and expand what is currently known from preclinical work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091
Endocrinology of the stress response
Charmandari, E., Tsigos, C., & Chrousos, G. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.120816 · Cited by 1,799 · cited 1×
“In humans, repeated and long-term exposure to stressors may dysregulate the HPA-axis and lead to pathological disturbances characterized by persistent anxiety (Charmandari et al., 2005; Engelmann et al., 2004).”
BackgroundOxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · cited 1×
“OT has emerged as a potential candidate for pharmacological treatment due to its endogenous involvement in facilitating social cognition and behavior and through support from some preclinical and human work using OT administration (Anagnostou et al., 2014; DeMayo et al., 2017; Meyer-Lindenberg et al., 2011).”
BackgroundLandgraf, R., & Neumann, I. D. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.05.001 · Cited by 1,059
Insel, T. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.03.005 · Cited by 1,044
The Social Salience Hypothesis of Oxytocin
Shamay-Tsoory, S. G., & Abu-Akel, A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.020 · Cited by 904 · cited 2×
“Also, OT-enhanced social salience may augment therapeutic effects (Lee et al., 2016a; Shamay-Tsoory and Abu-Akel, 2016).”
BackgroundOlff, M., Frijling, J. L., Kubzansky, L. D., Bradley, B., Ellenbogen, M. A., Cardoso, C., Bartz, J. A., Yee, J. R., & van Zuiden, M. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.06.019 · Cited by 620
The Peptide That Binds: A Systematic Review of Oxytocin and its Prosocial Effects in Humans
MacDonald, K., & MacDonald, T. M. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673220903523615 · Cited by 585 · cited 2×
“…single-dose and receptor studies on OT’s involvement in social cognition and behavior have led to investigations on chronic OT for the treatment of conditions characterized by social and cognitive dysfunction (Guastella and MacLeod, 2012; Kumsta and Heinrichs, 2013; MacDonald and Macdonald, 2010).”
BackgroundSocial modulation of stress responses
DeVries, A. C., Glasper, E. R., & Detillion, C. E. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00152-5 · Cited by 482 · cited 1×
“OT release has also been discussed as a physiological mechanism that facilitates social support and bonding associated with HPAaxis downregulation (DeVries et al., 2003).”
BackgroundOxytocin in general anxiety and social fear: a translational approach
Neumann, I. D., & Slattery, D. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.004 · Cited by 468
Striepens, N., Kendrick, K. M., Hanking, V., Landgraf, R., Wüllner, U., Maier, W., & Hurlemann, R. (2013) · Scientific Reports · doi:10.1038/srep03440 · Cited by 452 · cited 3×
“, ~two minutes in the blood and ~20 minutes in the central nervous system) (Mens et al., 1983; Striepens et al., 2013), any effects captured by single-dose trials may not be long-lasting.”
BackgroundMethodCarter, C. S. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80176-9 · Cited by 417 · cited 2×
“, 2014; Gimpl and Fahrenholz, 2001), recent work has more broadly investigated OT modulation of sexual function and behavior (Behnia et al., 2014; Burri et al., 2008; Carter, 1992).”
BackgroundWindle, R. J., Kershaw, Y. M., Shanks, N., Wood, S. A., Lightman, S. L., & Ingram, C. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-03.2004 · Cited by 408
Baskerville, T. A., & Douglas, A. J. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00154.x · Cited by 377 · cited 1×
“performance apparent in sexual desire/arousal disorders (Baskerville and Douglas, 2010).”
Developmental consequences of oxytocin
Carter, C. S. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00151-3 · Cited by 367
Mens, W. B. J., Witter, A., & Van Wimersma Greidanus, T. B. (1983) · Brain Research · doi:10.1016/0006-8993(83)90478-x · Cited by 360
A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research
MacDonald, E., Dadds, M. R., Brennan, J. L., Williams, K., Levy, F., & Cauchi, A. J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.02.015 · Cited by 359 · cited 4×
“The promise of OT administration as an investigative and therapeutic tool has also been supported by the minimal and inconsistent side effects observed in humans, primarily when administered intranasally and in single doses (MacDonald et al., 2011).”
BackgroundInfluentialGuastella, A. J., Hickie, I. B., McGuinness, M. M., Otis, M., Woods, E. A., Disinger, H. M., Chan, H.-K., Chen, T. F., & Banati, R. B. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.019 · Cited by 357
Oxytocin pathway gene networks in the human brain
Quintana, D. S., Rokicki, J., van der Meer, D., Alnæs, D., Kaufmann, T., Córdova-Palomera, A., Dieset, I., Andreassen, O. A., & Westlye, L. T. (2019) · Nature Communications · doi:10.1038/s41467-019-08503-8 · Cited by 354
Anagnostou, E., Soorya, L., Chaplin, W., Bartz, J., Halpern, D., Wasserman, S., Wang, A. T., Pepa, L., Tanel, N., Kushki, A., et al. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-16 · Cited by 350
Yatawara, C. J., Einfeld, S. L., Hickie, I. B., Davenport, T. A., & Guastella, A. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.162 · Cited by 344 · cited 1×
“Similarly, 12 IU over five weeks in children improved evaluations of social responsiveness (Yatawara et al., 2016).”
BackgroundInfluence of oxytocin on feeding behavior in the rat
Arletti, R., Benelli, A., & Bertolini, A. (1989) · Peptides · doi:10.1016/0196-9781(89)90082-x · Cited by 328 · cited 1×
“Chronic OT can induce weight loss in animals through physiological and neural mechanisms that increase the time between feedings and suppress food-related reward (Altirriba et al., 2015; Arletti et al., 1989; Blevins et al., 2015; Morton et al., 2012).”
BackgroundAdjunctive intranasal oxytocin reduces symptoms in schizophrenia patients
Feifel, D., Macdonald, K., Nguyen, A., Cobb, P., Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.039 · Cited by 308
Self-citationPedersen, C. A., Gibson, C. M., Rau, S. W., Salimi, K., Smedley, K. L., Casey, R. L., Leserman, J., Jarskog, L. F., & Penn, D. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.027 · Cited by 305 · cited 2×
“However, this study was limited by small sample size and a lack of data on cognition more broadly (Pedersen et al., 2011).”
BackgroundGuastella, A. J., Gray, K. M., Rinehart, N. J., Alvares, G. A., Tonge, B. J., Hickie, I. B., Keating, C. M., Cacciotti‐Saija, C., & Einfeld, S. L. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12305 · Cited by 299 · cited 1×
“In contrast, null findings on social outcomes in children have been observed (Dadds et al., 2014; Guastella et al., 2015).”
ResultGroeneweg, F. L., Karst, H., de Kloet, E. R., & Joëls, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.020 · Cited by 289 · cited 1×
“Glucocorticoid and mineralocorticoid receptors play roles in stress-response and -recovery and dysregulation of these receptors can increase the risk of stress-related disorders (Groeneweg et al., 2012; Petersson and Uvnäs-Moberg, 2003).”
BackgroundBethlehem, R. A. I., van Honk, J., Auyeung, B., & Baron-Cohen, S. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.10.011 · Cited by 285 · cited 3×
“effects on the endogenous OT system (Bethlehem et al., 2013).”
BackgroundShahrestani, S., Kemp, A. H., & Guastella, A. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.86 · Cited by 283
Bales, K. L., Perkeybile, A. M., Conley, O. G., Lee, M. H., Guoynes, C. D., Downing, G. M., Yun, C. R., Solomon, M., Jacob, S., & Mendoza, S. P. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.025 · Cited by 265 · cited 7×
“Within studies, interindividual factors can also moderate effects, including the sex (Bales et al., 2013) and genotype of the subject (Bales et al., 2014; Slattery and Neumann, 2010).”
BackgroundResultInfluentialSocial facilitation of wound healing
Detillion, C. E., Craft, T. K. S., Glasper, E. R., Prendergast, B. J., & DeVries, A. C. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.10.003 · Cited by 259
Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats
Deblon, N., Veyrat-Durebex, C., Bourgoin, L., Caillon, A., Bussier, A.-L., Petrosino, S., Piscitelli, F., Legros, J.-J., Geenen, V., Foti, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025565 · Cited by 254
Chang, S. W. C., Barter, J. W., Ebitz, R. B., Watson, K. K., & Platt, M. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114621109 · Cited by 252 · cited 1×
“, breath-powered devices, nebulizers) are being explored as they constitute more controlled methods of intranasal delivery to central targets (Chang et al., 2012; Quintana et al., 2016).”
BackgroundNasal oxytocin for social deficits in childhood autism: A randomized controlled trial
Dadds, M. R., MacDonald, E., Cauchi, A., Williams, K., Levy, F., & Brennan, J. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1899-3 · Cited by 250 · cited 2×
“Lack of significant effects could have been due to interindividual factors including variation in the diagnostic subtypes or participant age (Dadds et al., 2014).”
BackgroundResultOxytocin causes a long-term decrease of blood pressure in female and male rats
PETERSSON, M., ALSTER, P., LUNDEBERG, T., & UVNÄS-MOBERG, K. (1996) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00261-2 · Cited by 229
Marital behavior, oxytocin, vasopressin, and wound healing
Gouin, J.-P., Carter, C. S., Pournajafi-Nazarloo, H., Glaser, R., Malarkey, W. B., Loving, T. J., Stowell, J., & Kiecolt-Glaser, J. K. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.01.009 · Cited by 227 · cited 1×
“OT administration may modulate endogenous OT and inflammatory biomarker levels relevant for pain reduction/tolerance and wound healing (Clodi et al., 2008; Detillion et al., 2004; Gouin et al., 2010; Rash et al., 2014).”
BackgroundTreatment of obesity and diabetes using oxytocin or analogs in patients and mouse models
Zhang, H., Wu, C., Chen, Q., Chen, X., Xu, Z., Wu, J., & Cai, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061477 · Cited by 224 · cited 4×
“In humans, chronic OT may be an effective intervention for leptin-resistant obesity (Altirriba et al., 2015; Blevins et al., 2015; Zhang et al., 2013).”
BackgroundInfluentialGuastella, A. J., & Hickie, I. B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.028 · Cited by 223
Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism
Watanabe, T., Kuroda, M., Kuwabara, H., Aoki, Y., Iwashiro, N., Tatsunobu, N., Takao, H., Nippashi, Y., Kawakubo, Y., Kunimatsu, A., et al. (2015) · Brain · doi:10.1093/brain/awv249 · Cited by 222
Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass
Maejima, Y., Iwasaki, Y., Yamahara, Y., Kodaira, M., Sedbazar, U., & Yada, T. (2011) · Aging · doi:10.18632/aging.100408 · Cited by 220 · cited 3×
“, 2017); adipocyte size (Balazova et al., 2016; Eckertova et al., 2011; Maejima et al., 2011); and body fat (Blevins et al.”
BackgroundPeripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats
Morton, G. J., Thatcher, B. S., Reidelberger, R. D., Ogimoto, K., Wolden-Hanson, T., Baskin, D. G., Schwartz, M. W., & Blevins, J. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00296.2011 · Cited by 213 · cited 6×
“…reductions in caloric intake (Balazova et al., 2016; Blevins et al., 2016, 2015; Deblon et al., 2011; Iwasaki et al., 2015; Maejima et al., 2011; Morton et al., 2012; Roberts et al., 2017; Uvnäs-Moberg et al., 1996); weight (Balazova et al., 2016; Blevins et al., 2016, 2015; Deblon et al.,…”
BackgroundInfluentialOxytocin revisited: Its role in cardiovascular regulation
Gutkowska, J., & Jankowski, M. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02235.x · Cited by 208 · cited 1×
“OT-related cardiovascular influence is indicated by the presence of OXTR in the heart of animals and humans (Grewen and Light, 2011; Gutkowska and Jankowski, 2012) and the coordinated response of the endogenous OT system (e.”
BackgroundIntranasal oxytocin administration attenuates the ACTH stress response in monkeys
Parker, K. J., Buckmaster, C. L., Schatzberg, A. F., & Lyons, D. M. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.002 · Cited by 204
Chronic and acute intranasal oxytocin produce divergent social effects in mice
Huang, H., Michetti, C., Busnelli, M., Managò, F., Sannino, S., Scheggia, D., Giancardo, L., Sona, D., Murino, V., Chini, B., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.310 · Cited by 199 · cited 5×
“Dosages for animal models are often weightadjusted to reflect similar amounts given to humans or other well-established models of OT function like the prairie vole (Bales et al., 2014; Guoynes et al., 2018; Huang et al., 2014).”
BackgroundMethodResultInfluentialIntranasal oxytocin blocks alcohol withdrawal in human subjects
Pedersen, C. A., Smedley, K. L., Leserman, J., Jarskog, L. F., Rau, S. W., Kampov‐Polevoi, A., Casey, R. L., Fender, T., & Garbutt, J. C. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01958.x · Cited by 196
Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats
Slattery, D. A., & Neumann, I. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.038 · Cited by 195
Crockford, C., Deschner, T., Ziegler, T. E., & Wittig, R. M. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00068 · Cited by 187 · cited 1×
“6 Social engagement and bonding—Investigation of OT’s involvement in social engagement and bonding in healthy subjects has the potential to inform the treatment of social deficits, with consideration of contextual and interindividual variability (Calcagnoli et al., 2014; Crockford et al., 2014).”
BackgroundMacDonald, K., & Feifel, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00035 · Cited by 181
Self-citationCSF and blood oxytocin concentration changes following intranasal delivery in macaque
Dal Monte, O., Noble, P. L., Turchi, J., Cummins, A., & Averbeck, B. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103677 · Cited by 177
Oxytocin and Pain: A Systematic Review and Synthesis of Findings
Rash, J. A., Aguirre-Camacho, A., & Campbell, T. S. (2014) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31829f57df · Cited by 175 · cited 8×
“OT administration may modulate endogenous OT and inflammatory biomarker levels relevant for pain reduction/tolerance and wound healing (Clodi et al., 2008; Detillion et al., 2004; Gouin et al., 2010; Rash et al., 2014).”
BackgroundInfluentialThe acute effects of intranasal oxytocin administration on endocrine and sexual function in males
Burri, A., Heinrichs, M., Schedlowski, M., & Kruger, T. H. C. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.01.014 · Cited by 168
Oxytocin enhances observational fear in mice
Pisansky, M. T., Hanson, L. R., Gottesman, I. I., & Gewirtz, J. C. (2017) · Nature Communications · doi:10.1038/s41467-017-02279-5 · Cited by 167 · cited 2×
“indicate that rather than universally attenuating stress and anxiety, it is possible that chronic OT selectively enhances certain stressful experiences to motivate prosocial behavior (Pisansky et al., 2017).”
BackgroundYang, J. (1994) · Spine · doi:10.1097/00007632-199404150-00001 · Cited by 157
Anagnostou, E., Soorya, L., Brian, J., Dupuis, A., Mankad, D., Smile, S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.049 · Cited by 155 · cited 6×
“OT has emerged as a potential candidate for pharmacological treatment due to its endogenous involvement in facilitating social cognition and behavior and through support from some preclinical and human work using OT administration (Anagnostou et al., 2014; DeMayo et al., 2017; Meyer-Lindenberg et al., 2011).”
BackgroundInfluentialTachibana, M., Kagitani-Shimono, K., Mohri, I., Yamamoto, T., Sanefuji, W., Nakamura, A., Oishi, M., Kimura, T., Onaka, T., Ozono, K., et al. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0048 · Cited by 151 · cited 4×
“Also, the outcome measures or dosages used may have been insensitive to behavioral effects (DeMayo et al., 2017; Tachibana et al., 2013).”
BackgroundInfluentialQuintana, D. S., Alvares, G. A., Hickie, I. B., & Guastella, A. J. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.011 · Cited by 149
Iwasaki, Y., Maejima, Y., Suyama, S., Yoshida, M., Arai, T., Katsurada, K., Kumari, P., Nakabayashi, H., Kakei, M., & Yada, T. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00344.2014 · Cited by 148
Carson, D. S., Cornish, J. L., Guastella, A. J., Hunt, G. E., & McGregor, I. S. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.018 · Cited by 146 · cited 1×
“Efficacy of chronic OT pretreatment was found to be dose-dependent for methamphetamine self-administration, with higher OT doses associated with reduced drug responding (Carson et al., 2010).”
BackgroundBowen, M. T., Carson, D. S., Spiro, A., Arnold, J. C., & McGregor, I. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027237 · Cited by 143 · cited 6×
“Regarding alcohol, peripheral OT administered daily resulted in reduced consumption in rats (Bowen et al., 2011), mild withdrawal symptoms in mice (Szabó et al.”
BackgroundResultInfluentialDevelopmental experiences and the oxytocin receptor system
Bales, K. L., & Perkeybile, A. M. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.013 · Cited by 142 · cited 1×
“Box 3: Chronic OT across development Chronic OT in early development: Preclinical studies have indicated that developmental trajectories can shift as a result of exogenous OT either during prenatal or postnatal development (Bales and Perkeybile, 2012; Carter, 2003; Guoynes et al., 2018).”
BackgroundOxytocin׳s role in anxiety: A critical appraisal
MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139
Self-citationvan Zuiden, M., Frijling, J. L., Nawijn, L., Koch, S. B. J., Goslings, J. C., Luitse, J. S., Biesheuvel, T. H., Honig, A., Veltman, D. J., & Olff, M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.11.012 · Cited by 134
The role of central oxytocin in obsessive compulsive disorder and related normal behavior
Leckman, J. F., Goodman, W. K., North, W. G., Chappell, P. B., Price, L. H., Pauls, D. L., Anderson, G. M., Riddle, M. A., McDougle, C. J., Barr, L. C., et al. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90021-3 · Cited by 133 · cited 1×
“Some evidence has linked OCD to over-activation of the endogenous OT system whereas others have theorized that OT administration may help treat OCD symptoms, based on findings that low doses of OT attenuate memory and anxiety (Leckman et al., 1994).”
BackgroundA double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome
Einfeld, S. L., Smith, E., McGregor, I. S., Steinbeck, K., Taffe, J., Rice, L. J., Horstead, S. K., Rogers, N., Hodge, M. A., & Guastella, A. J. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36653 · Cited by 131 · cited 9×
“Without this scaffolding, chronic OT may not sufficiently upregulate the endogenous system (Einfeld et al., 2014).”
BackgroundResultInfluentialAerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques
Modi, M. E., Connor-Stroud, F., Landgraf, R., Young, L. J., & Parr, L. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.02.011 · Cited by 129 · cited 1×
“Administration through a nebulizer may be more effective than a nasal spray (Calcagnoli et al., 2015; Modi et al., 2014).”
BackgroundCacciotti-Saija, C., Langdon, R., Ward, P. B., Hickie, I. B., Scott, E. M., Naismith, S. L., Moore, L., Alvares, G. A., Redoblado Hodge, M. A., & Guastella, A. J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu094 · Cited by 119
Kosaka, H., Okamoto, Y., Munesue, T., Yamasue, H., Inohara, K., Fujioka, T., Anme, T., Orisaka, M., Ishitobi, M., Jung, M., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.152 · Cited by 117 · cited 1×
“Another multiweek, multidose clinical trial in adolescents and young adults found that higher (32 IU) compared to lower (16 IU) doses were associated with greater global functioning after 12 weeks (Kosaka et al., 2016).”
BackgroundA Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia
Feifel, D., Shilling, P. D., & MacDonald, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.025 · Cited by 110
Self-citationBehnia, B., Heinrichs, M., Bergmann, W., Jung, S., Germann, J., Schedlowski, M., Hartmann, U., & Kruger, T. H. C. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.01.009 · Cited by 103
Quintana, D. S., Westlye, L. T., Rustan, Ø. G., Tesli, N., Poppy, C. L., Smevik, H., Tesli, M., Røine, M., Mahmoud, R. A., Smerud, K. T., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.93 · Cited by 103 · cited 6×
“Specifically, the low-dose reduced the perception of anger from ambiguous faces (Quintana et al., 2015b) and reduced amygdala response to angry faces (Quintana et al., 2016).”
BackgroundInfluentialQuintana, D. S., Westlye, L. T., Alnæs, D., Rustan, Ø. G., Kaufmann, T., Smerud, K. T., Mahmoud, R. A., Djupesland, P. G., & Andreassen, O. A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.04.010 · Cited by 102 · cited 3×
“Common dosages for single administration of OT nasal spray are between 24 and 40 IU but can be as low as 8 IU for humans (Guastella et al., 2013; Quintana et al., 2016).”
BackgroundProsocial effects of oxytocin in two mouse models of autism spectrum disorders
Teng, B. L., Nonneman, R. J., Agster, K. L., Nikolova, V. D., Davis, T. T., Riddick, N. V., Baker, L. K., Pedersen, C. A., Jarstfer, M. B., & Moy, S. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.038 · Cited by 98
Rault, J.-L., Carter, C. S., Garner, J. P., Marchant, J. N., Richert, B. T., & Lay, D. C. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.02.007 · Cited by 94 · cited 5×
“Other preclinical work, however, has shown that chronic OT increased (Peters et al., 2014; Rault et al., 2013) or had no effect on certain correlates of stress and anxiety (Bales et al.”
BackgroundResultInfluentialUvnäs-Moberg, K., Alster, P., Petersson, M., Sohlström, A., & Björkstrand, E. (1998) · Pediatric Research · doi:10.1203/00006450-199803000-00006 · Cited by 94 · cited 2×
“In contrast, postnatal chronic OT administered peripherally to rat pups over five days resulted in long-term positive physical and metabolic changes that were similar to the benefits observed in kangaroo care for premature infants (Uvnäs-Moberg et al., 1998).”
BackgroundResultAlvares, G. A., Quintana, D. S., & Whitehouse, A. J. O. (2017) · Autism Research · doi:10.1002/aur.1692 · Cited by 91 · cited 1×
“Research has focused on the modulatory effects of OT administration in addition to the mechanisms underlying these effects relative to endogenous functions (Alvares et al., 2017; Du Vigneaud, 1956).”
BackgroundLong-term oxytocin administration enhances the experience of attachment
Bernaerts, S., Prinsen, J., Berra, E., Bosmans, G., Steyaert, J., & Alaerts, K. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.010 · Cited by 90
Intranasal oxytocin in obsessive-compulsive disorder
Epperson, C. N., McDougle, C. J., & Price, L. H. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(96)00120-5 · Cited by 88 · cited 1×
“However, a one-week treatment with much higher doses (160 IU and 320 IU per day) still showed no improvement in OCD symptoms (Epperson et al., 1996).”
BackgroundOxytocin’s effect on resting-state functional connectivity varies by age and sex
Ebner, N. C., Chen, H., Porges, E., Lin, T., Fischer, H., Feifel, D., & Cohen, R. A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.03.013 · Cited by 84
Self-citationMunesue, T., Nakamura, H., Kikuchi, M., Miura, Y., Takeuchi, N., Anme, T., Nanba, E., Adachi, K., Tsubouchi, K., Sai, Y., et al. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00002 · Cited by 84 · cited 2×
“Although there seem to be some benefits of chronic OT administration, it is important to note that some studies reported null findings on the improvement of core symptoms relating to ASD in adults (Anagnostou et al., 2012; Munesue et al., 2016) and youth (Dadds et al.”
BackgroundResultLee, M. R., Wehring, H. J., McMahon, R. P., Linthicum, J., Cascella, N., Liu, F., Bellack, A., Buchanan, R. W., Strauss, G. P., Contoreggi, C., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.001 · Cited by 80
Oxytocin and socioemotional aging: current knowledge and future trends
Ebner, N. C., Maura, G. M., MacDonald, K., Westberg, L., & Fischer, H. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00487 · Cited by 78 · cited 2×
“, ASD, PWS) (Carter, 2003; Young, 2013) as well as in healthy and pathological aging (Ebner et al., 2013; Finger et al., 2015).”
BackgroundSelf-citationEckertova, M., Ondrejcakova, M., Krskova, K., Zorad, S., & Jezova, D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01037.x · Cited by 68
Effects of a 10-day oxytocin trial in older adults on health and well-being
Barraza, J. A., Grewal, N. S., Ropacki, S., Perez, P., Gonzalez, A., & Zak, P. J. (2013) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0031581 · Cited by 61
Yamasue, H. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12364 · Cited by 58
Oxytocin nasal spray in fibromyalgic patients
Mameli, S., Pisanu, G. M., Sardo, S., Marchi, A., Pili, A., Carboni, M., Minerba, L., Trincas, G., Carta, M. G., Melis, M. R., et al. (2014) · Rheumatology International · doi:10.1007/s00296-014-2953-y · Cited by 54 · cited 4×
“crossover study among fibromyalgia patients found no therapeutic effects of daily intranasal OT administration (80 IU) for three weeks when used in conjunction with nonsteroidal painkillers (Mameli et al., 2014).”
BackgroundMethodInfluentialQuintana, D. S., Dieset, I., Elvsåshagen, T., Westlye, L. T., & Andreassen, O. A. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.12.004 · Cited by 39
When too much of a good thing is bad: chronic oxytocin, development, and social impairments
Young, L. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.015 · Cited by 22 · cited 6×
“Safety and tolerability in early and later life: Evaluation for safety and long-term consequences of chronic OT across development is needed in light of its potential therapeutic use in early-life developmental disorders (e.g., ASD, PWS) (Carter, 2003; Young, 2013) as well as in healthy and pathological aging (Ebner e…”
BackgroundInfluentialTirelli, E., Jodogne, C., & Legros, J.-J. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90512-e · Cited by 18 · cited 1×
“Peripheral OT pretreatment may specifically disrupt conditioning related to alcohol tolerance (Tirelli et al., 1992).”
Background
Cited by
Quintana, D. S., Lischke, A., Grace, S., Scheele, D., Ma, Y., & Becker, B. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00864-7 · Cited by 263
“Second, it is unclear whether chronic administration of oxytocin will emerge as a long-term treatment for patients [146], or if short-term adjunctive treatment with oxytocin might be more appropriate.”
BackgroundAdvances in human oxytocin measurement: challenges and proposed solutions
Tabak, B. A., Leng, G., Szeto, A., Parker, K. J., Verbalis, J. G., Ziegler, T. E., Lee, M. R., Neumann, I. D., & Mendez, A. J. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01719-z · Cited by 170
“Also, the effectiveness of chronic oxytocin administration in humans needs to be studied further as adverse behavioral and cellular effects of chronic oxytocin treatment have been shown in rodents [69, 70].”
BackgroundFlanagan, J. C., Nietert, P. J., Sippel, L., Jarnecke, A. M., Kirby, C., Hogan, J. N., Massa, A. A., Brower, J., Back, S. E., & Parrott, D. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.06.011 · Cited by 16
Sippel, L. M., Wachsman, T. R., Kelley, M. E., Knopp, K. C., Khalifian, C. E., Maglione, J. E., Glynn, S. M., Macdonald, A., Monson, C. M., Flanagan, J. C., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107534 · Cited by 4
Metadata
- Authors
- Horta, M., Kaylor, K., Feifel, D., & Ebner, N. C.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 108
- Pages
- 1-23
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2982236498
- Cited by
- 63
- References
- 88
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.